Amarin Corp Plc (AMRN)

[sstyles]

Pay attention to "conduct" of the generics and what would be deemed inducing infringement of the pioneer patent for REDUCE-IT.

The generics have approval for the Marine Indication (TGs of 500 and greater). Lets say the population of this very high TG group is Y million. I don't know the exact figure. If the generics are producing Y times X multiple to serve this group that would seem they are going after a larger population (REDUCE-IT). They don't have approval for that.

I imagine historical prescriptions could shed light on population of Marine TG group. Amarin's own materials say this is a niche population.

Prescription numbers going forward would be telling in more ways than one. The numbers would not lie.

This is what JL was alluding too when he said they would be infringing on the REDUCE-IT patent. Amarin needs to be more vocal about this to Wall Street.